Clinical Trial Update: Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dorzagliatin effects on first-phase insulin response and beta-cell glucose sensitivity in type 2 diabetes and monogenic diabetes; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dorzagliatin (dorzagliatin)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED